e-Drug3D

807

RIVASTIGMINE


INN
RIVASTIGMINE

cas 123441-03-2
CLASS

NERVOUS SYSTEM
CHOLINERGIC AGENTS
CHOLINESTERASE INHIBITORS
NEUROPROTECTIVE AGENTS
ALZHEIMER
PARKINSON’S DISEASE

ROUTE (list)

ORAL TRANSDERMAL

ATC code

N06DA03

PK parameters

F 40 PERCENT
Tmax 1 HOUR
VD 146.2 LITER (65 KILOGRAM)
Cl 108 LITER / HOUR
PPB 40 PERCENT
t1/2 1.5 HOUR

Solubility

VERY SOLUBLE IN WATER


Target

TARGET CHOLINESTERASE

DrugCentral

Acetylcholinesterase UNIPROT P22303 ACHE

Cholinesterase UNIPROT P06276 BCHE

Download SDF file [3-[(1S)-1-dimethylaminoethyl]phenyl] N-ethyl-N-methylcarbamate

Formula:
C14H22N2O2

Calculated chemical properties:

MW 250.34
NB_atoms 18
XLogP 2.76
PSA 32.561
NB_HD 0
NB_HA 4
fsp3 0.50
Lipinski(0=no;1=yes) 1

FDA
NDA 020823 (pdf not found) INN (RIVASTIGMINE TARTRATE) EXELON (NOVARTIS) APPROVAL= AP YEAR= 2000 DISCONTINUED
NDA 021025 (pdf not found) INN (RIVASTIGMINE TARTRATE) EXELON (NOVARTIS) APPROVAL= AP YEAR= 2000 DISCONTINUED
NDA 077363 (pdf not found) INN (RIVASTIGMINE TARTRATE) RIVASTIGMINE (RANBAXY) APPROVAL= TA YEAR= 2005
NDA 022083 (pdf not found) INN (RIVASTIGMINE) EXELON (SANDOZ) APPROVAL= AP YEAR= 2007
NDA 077130 (pdf not found) INN (RIVASTIGMINE TARTRATE) RIVASTIGMINE TARTRATE (DR REDDYS LABS INC) APPROVAL= AP YEAR= 2007
NDA 077131 (pdf not found) INN (RIVASTIGMINE TARTRATE) RIVASTIGMINE TARTRATE (SUN PHARM) APPROVAL= AP YEAR= 2007 DISCONTINUED
NDA 077129 (pdf not found) INN (RIVASTIGMINE TARTRATE) RIVASTIGMINE TARTRATE (WATSON LABS) APPROVAL= AP YEAR= 2008
NDA 091689 (pdf not found) INN (RIVASTIGMINE TARTRATE) RIVASTIGMINE TARTRATE (ALEMBIC PHARMS LTD) APPROVAL= AP YEAR= 2012
NDA 091072 (pdf not found) INN (RIVASTIGMINE TARTRATE) RIVASTIGMINE TARTRATE (APOTEX INC) APPROVAL= AP YEAR= 2013 DISCONTINUED
NDA 203148 (pdf not found) INN (RIVASTIGMINE TARTRATE) RIVASTIGMINE TARTRATE (MACLEODS PHARMS LTD) APPROVAL= AP YEAR= 2014
NDA 090879 (pdf not found) INN (RIVASTIGMINE TARTRATE) RIVASTIGMINE TARTRATE (ORBION PHARMS) APPROVAL= AP YEAR= 2015
NDA 204403 (pdf not found) INN (RIVASTIGMINE) RIVASTIGMINE (ALVOGEN) APPROVAL= AP YEAR= 2015 DISCONTINUED
NDA 204572 (pdf not found) INN (RIVASTIGMINE TARTRATE) RIVASTIGMINE TARTRATE (AUROBINDO PHARMA) APPROVAL= AP YEAR= 2016
NDA 203844 (pdf not found) INN (RIVASTIGMINE TARTRATE) RIVASTIGMINE TARTRATE (CADILA PHARMS LTD) APPROVAL= AP YEAR= 2017
NDA 207797 (pdf not found) INN (RIVASTIGMINE TARTRATE) RIVASTIGMINE TARTRATE (CHARTWELL RX) APPROVAL= AP YEAR= 2017
NDA 205622 (pdf not found) INN (RIVASTIGMINE) RIVASTIGMINE (MYLAN TECHNOLOGIES) APPROVAL= AP YEAR= 2018
NDA 206318 (pdf not found) INN (RIVASTIGMINE) RIVASTIGMINE (ZYDUS PHARMS) APPROVAL= AP YEAR= 2019
NDA 207308 (pdf not found) INN (RIVASTIGMINE) RIVASTIGMINE (AMNEAL PHARMS) APPROVAL= AP YEAR= 2019
NDA 209063 (pdf not found) INN (RIVASTIGMINE) RIVASTIGMINE (BRECKENRIDGE) APPROVAL= AP YEAR= 2019

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL